рус
eng
Strategic consulting
Developing market access strategy Development of marketing strategy Portfolio assessment and development Registration dossier and market authorization
Ongoing analytical review of the Russian health care system
PharmСompass Russia PharmСompass Regions PharmCompass ЕАСU
Market research Pharmacoeconomic analysis Patient support programs
Clinical patient registries
Diabetes Mellitus Rheumatoid Arthritis (RA) Juvenile Arthritis Hemic Diseases Pituitary Tumours mRCC Diabetic Foot Syndrome Medullary Thyroid Cancer Diabetes Insipidus Other registries
Epidemiological studies Laboratory diagnostics programs Biostatistics Clinical trials Pharmacovigilance programs
BI solutions Quinta platform and Quinta solutions
Quinta Clinical Quinta Care Quinta Lab
Websites and educations web-portals Mobile apps Expert Systems
Analytical products
Aston 360 Report PharmСompass Russia Report PharmСompass Regions Report PharmCompass ЕEU
PharMon databases
PharMon Tenders PharMon Import
Expert Audit BI solutions
Exspertize » Therapeutic areas » Urology and nephrology
Anastasia Zhigalkina

Urology and nephrology

The main focus of Aston Group’s research in urology and nephrology is related to dialysis (peritoneal and hemodialysis) and possible cancer complications.

We have conducted multi-wave studies to track the changes in treatment over time (emergence of new therapies, programs for patients, etc.).

Projects on urology and nephrology have broad geographical scope (from Khabarovsk to Murmansk), which allows our research team to accumulate unique data pertaining to specifics of care provision to patients with kidney disease.

 

Others therapeutic areas

CJSC Aston Consulting, 1999-2021
General Policy on Processing of Personal Data